Document Detail


Criteria for treatment of neonatal jaundice.
MedLine Citation:
PMID:  11803425     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Treatment of neonatal hyperbilirubinemia is usually based on the measurements of total serum bilirubin levels. Based on empirical data, it is generally recommended to start phototherapy at lower levels in low birth weight and very low birth weight infants than in term infants, but no general agreement exists on exact limits. Treatment criteria in preterm infants do not, however, have the same empirical backing as in term infants. The very low and extremely low birth weight infants are more susceptible to bilirubin toxicity. However, bilirubin may function as an antioxidant and enzyme inducer in these infants. Several other different approaches to establish treatment criteria have also been suggested, and a summary of these are presented and discussed. With the exception of measurement of unbound bilirubin, very few of these approaches have been validated in routine clinical settings. However, unbound bilirubin is at present mainly used also as a parameter to be evaluated in relation to total bilirubin values. The present treatment criteria result in a considerable overtreatment particularly of term infants. However, with a more relaxed attitude toward neonatal hyperbilirubinemia by health care professionals, kernicterus is again reported in term infants. Because the basic mechanisms of bilirubin toxicity as well as the relative significance of the maximum serum bilirubin level compared to the duration of hyperbilirubinemia are not known, individual assessment of a newborn infant's tolerance for hyperbilirubinemia is difficult. Major changes in the empirically developed criteria for treatment of hyperbilirubinemia in the newborn are therefore not justified in the near future. For term infants, the search for validated criteria for follow-up of jaundiced infants after discharge are therefore more important than revision of existing criteria for phototherapy.
Authors:
D Bratlid
Related Documents :
8985525 - Henna (lawsonia inermis linn.) inducing haemolysis among g6pd-deficient newborns. a new...
957015 - The effect of maternally administered drugs on bilirubin concentrations in the newborn ...
5543875 - Endogenous production of carbon monoxide in normal and erythroblastotic newborn infants.
7923775 - Bilirubin production in healthy term infants as measured by carbon monoxide in breath.
17669105 - Helicobacter pylori colonization in the first 3 years of life in japanese children.
8018135 - The management of acute bronchiolitis. thoracic society of australia and new zealand.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  21 Suppl 1     ISSN:  0743-8346     ISO Abbreviation:  J Perinatol     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-01-22     Completed Date:  2002-02-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S88-92; discussion S104-7     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Faculty of Medicine, University Hospital, Norwegian University of Science and Technology, Regionsykehuset i Trondheim, 7006 Trondheim, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bilirubin / blood
Humans
Infant, Low Birth Weight
Infant, Newborn
Infant, Very Low Birth Weight
Jaundice, Neonatal / complications,  diagnosis,  therapy*
Kernicterus / prevention & control
Phototherapy
Chemical
Reg. No./Substance:
635-65-4/Bilirubin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prediction of hyperbilirubinemia in near-term and term infants.
Next Document:  Phototherapy--traditional and nontraditional.